![C. Nicholson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
C. Nicholson
Direktor/Vorstandsmitglied bei
ACTINIUM PHARMACEUTICALS, INC.
Vermögen: 420 $ am 31.05.2026
Profil
C.
David Nicholson is Chairman at Exscientia AI Ltd. since 2020.
Non-Executive Chairman at Wild Bioscience Ltd. since 2023.
Director at Rapalogix Health, Inc., Science Exchange, Inc. since 2018, Tarus Therapeutics, Inc. since 2020, Volastra Therapeutics, Inc., and Gilde Healthcare Partners, Inc. since 2020.
Lead Independent Director at Actinium Pharmaceuticals, Inc. since 2017.
Former Non-Executive Chairman at Exscientia Ltd. from 2023 to 2024.
Vice Chairman at Transcelerate Biopharma, Inc. Former Director at Actinium Pharmaceuticals, Inc. Director at Cactus Ventures, Inc. from 2012 to 2013.
Independent Director at Adverum Biotechnologies, Inc. from 2023 to 2025.
Senior Vice President at Forest Laboratories, Inc. Vice President-Licensing & Knowledge Management at Merck & Co., Inc. from 2009 to 2011.
SVP-Global Project Management & Drug Safety at Schering-Plough Corp.
from 2007 to 2009.
Chief Technology Officer & Executive VP at Bayer CropScience AG from 2012 to 2014.
Executive Vice President-Research & Development at Organon International, Inc. from 1988 to 2007 and at Organon Biosciences, Inc. in 2007.
Executive VP, Chief Research & Development Officer at Allergan UC from 2015 to 2020.
CTO, Head-Research & Development at Bayer Crop Science Solutions LLC from 2012 to 2014.
Education includes an undergraduate degree from The University of Manchester in 1975 and a doctorate from The University of Wales in 1980.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.10.2025 | 333 ( 0 % ) | 420 $ | 31.05.2026 |
Aktive Positionen von C. Nicholson
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.01.2008 |
Science Exchange, Inc.
 Science Exchange, Inc. Packaged SoftwareTechnology Services Provides life sciences procurement and supplier management SaaS solutions for biotech companies | Direktor/Vorstandsmitglied | 28.06.2018 |
Gilde Healthcare Partners, Inc.
 Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01.09.2020 |
Volastra Therapeutics, Inc.
 Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Direktor/Vorstandsmitglied | - |
WILD BIOSCIENCE LTD
 WILD BIOSCIENCE LTD Miscellaneous Commercial ServicesCommercial Services Operates as a crop improvement company that provides carbon mitigation, yield enhancement and farm productivity solutions | Vorsitzender | 03.11.2023 |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Vorsitzender | 01.10.2020 |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Direktor/Vorstandsmitglied | 14.05.2020 |
Ehemalige bekannte Positionen von C. Nicholson
| Unternehmen | Position | Ende |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | 09.12.2025 |
| EXSCIENTIA PLC | Vorsitzender | 12.02.2024 |
| ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von C. Nicholson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
22
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 22 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
 Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
 Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer CropScience AG
 Bayer CropScience AG Chemicals: AgriculturalProcess Industries Manufactures and distributes pesticides, and vegetable seeds | Process Industries |
Organon International, Inc.
 Organon International, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
The University of Wales
 The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon Biosciences, Inc. | |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products | Health Technology |
Science Exchange, Inc.
Science Exchange, Inc. Packaged SoftwareTechnology Services Provides life sciences procurement and supplier management SaaS solutions for biotech companies | Technology Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Gilde Healthcare Partners, Inc.
Gilde Healthcare Partners, Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Health Technology |
Bayer Crop Science Solutions LLC
 Bayer Crop Science Solutions LLC Part of Bayer AG, Bayer Crop Science Solutions LLC is a company that specializes in the Life Science fields of health care and agriculture. The company offers innovative solutions to prevent, alleviate, and treat diseases in both humans and crops. The company provides tailored solutions for farmers to plant, grow, and protect their crops using sustainable practices. Bayer is a leader in healthcare, with a focus on digestive health issues such as heartburn, gas, and indigestion. The company is based in St. Louis, MO and has a long history dating back to the discovery of the dye fuchsine. | |
Exscientia Plc
 Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
WILD BIOSCIENCE LTD
WILD BIOSCIENCE LTD Miscellaneous Commercial ServicesCommercial Services Operates as a crop improvement company that provides carbon mitigation, yield enhancement and farm productivity solutions | Commercial Services |
